Pedro Rosa-Neto Selected Research

Intracranial Hypertension

1/2022

Amyloid processing in COVID-19-associated neurological syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Rosa-Neto Research Topics

Disease

122	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 09/2008
57	Cognitive Dysfunction 05/2024 - 01/2012
54	Dementia (Dementias) 05/2024 - 06/2012
15	Atrophy 05/2024 - 01/2016
9	Disease Progression 05/2024 - 12/2011
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 03/2014
6	Amyloidosis 12/2023 - 12/2010
6	Gliosis 11/2023 - 12/2010
6	Neuroinflammatory Diseases 01/2023 - 01/2013
5	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 03/2014
5	Neoplasms (Cancer) 01/2019 - 02/2015
4	Memory Disorders (Memory Loss) 11/2023 - 09/2008
4	Temporal Lobe Epilepsy 01/2022 - 12/2013
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
3	Inflammation (Inflammations) 11/2023 - 01/2019
3	Tauopathies 01/2022 - 03/2014
3	Pain (Aches) 01/2022 - 10/2009
3	Brain Diseases (Brain Disorder) 01/2022 - 01/2013
3	Amyloid Plaque 12/2020 - 01/2016
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020 - 03/2017
2	Craniocerebral Trauma (Head Injury) 11/2023 - 01/2023
2	Clinical Deterioration 02/2023 - 01/2023
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023 - 04/2005
2	Neurobehavioral Manifestations 01/2022 - 11/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2021
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2022 - 01/2021
2	Guillain-Barre Syndrome 01/2022 - 01/2021
2	Focal Cortical Dysplasia 01/2021 - 10/2016
2	Fibrosis (Cirrhosis) 01/2011 - 12/2010
1	Hypoxia (Hypoxemia) 03/2024
1	Asphyxia (Suffocation) 03/2024
1	Autistic Disorder (Autism) 01/2024
1	Substance-Related Disorders (Drug Abuse) 11/2023
1	Mental Disorders (Mental Disorder) 07/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Obesity 01/2023
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2022
1	Necrosis 01/2022
1	Intracranial Hypertension 01/2022
1	Fatal Familial Insomnia 01/2022

Drug/Important Bio-Agent (IBA)

83	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2011
74	Amyloid (Amyloid Fibrils)IBA 05/2024 - 09/2008
11	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2008
10	AZD4694IBA 07/2023 - 01/2020
8	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2010
8	Amyloid beta-PeptidesIBA 02/2022 - 09/2008
7	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2016
7	Cholinergic Agents (Cholinergics)IBA 11/2021 - 12/2010
6	ApolipoproteinsIBA 01/2024 - 01/2020
6	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2022 - 12/2013
6	florbetapirIBA 10/2021 - 06/2017
5	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 10/2021 - 01/2020
4	Indicators and Reagents (Reagents)IBA 05/2024 - 07/2017
4	tau Proteins (tau Protein)IBA 01/2023 - 03/2014
4	Glial Fibrillary Acidic ProteinIBA 01/2023 - 01/2021
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2022 - 01/2018
4	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2021 - 04/2016
3	LigandsIBA 09/2023 - 01/2013
3	Dopamine (Intropin)FDA LinkGeneric 10/2022 - 09/2004
3	Naproxen (Naprosyn)FDA LinkGeneric 06/2019 - 01/2015
3	Pioglitazone (Actos)FDA Link 01/2013 - 09/2008
2	Serotonin (5 Hydroxytryptamine)IBA 03/2024 - 09/2004
2	Peptides (Polypeptides)IBA 06/2023 - 09/2008
2	Protein Isoforms (Isoforms)IBA 01/2023 - 12/2021
2	EpitopesIBA 12/2022 - 02/2022
2	martinostatIBA 10/2022 - 01/2022
2	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2022 - 01/2021
2	fluoroethoxy-benzovesamicolIBA 11/2021 - 01/2013
2	FluorineIBA 11/2021 - 01/2020
2	THK5351IBA 01/2019 - 03/2017
2	Retinaldehyde (Retinal)IBA 01/2019 - 01/2019
2	TropomyosinIBA 01/2017 - 02/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 02/2015
2	AntioxidantsIBA 01/2011 - 09/2008
1	IceIBA 01/2024
1	MK-6240IBA 09/2023
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	EndocannabinoidsIBA 01/2023
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	AminesIBA 01/2023
1	Prion ProteinsIBA 11/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	InterleukinsIBA 01/2022
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022
1	CytokinesIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	neuromelaninIBA 01/2022
1	NeurograninIBA 01/2022
1	alpha-SynucleinIBA 01/2022
1	Cell Adhesion MoleculesIBA 12/2021
1	CarbonIBA 12/2021

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2013
2	Contraindications 11/2023 - 01/2023
2	Denervation 11/2021 - 01/2021
1	Immunotherapy 01/2023